The rural disadvantage - prostate cancer outcomes of rural and urban patients over 25 years

  • 0Department of Surgery, Division of Urology, University of Alberta, Edmonton, Canada.

Summary

This summary is machine-generated.

Rural men face worse prostate cancer outcomes and higher mortality rates compared to urban men, despite universal healthcare. Targeted interventions are needed to address these geographic disparities in cancer care.

Area Of Science

  • Oncology
  • Public Health
  • Epidemiology

Background

  • Prostate cancer is a leading cause of cancer-related death in men.
  • Geographic location influences prostate cancer incidence and outcomes.
  • Disparities in cancer care persist even within universal healthcare systems.

Purpose Of The Study

  • To evaluate long-term trends in prostate cancer outcomes between rural and urban populations.
  • To identify persistent disparities in cancer-specific mortality despite universal healthcare access.
  • To inform targeted interventions for rural prostate cancer patients.

Main Methods

  • Retrospective cohort study using data from the Alberta Cancer Registry and Alberta Prostate Cancer Research Initiative (APCaRI).
  • Inclusion of over 45 million person-years of data from 1999-2022.
  • Categorization of residence as urban or rural based on postal codes to analyze prostate cancer-specific mortality.

Main Results

  • Rural men were diagnosed at older ages and had significantly higher age-adjusted prostate cancer-specific mortality rates (52.0 vs. 37.6 deaths per 100,000).
  • While both urban and rural areas showed improvements over time, rural areas consistently exhibited higher mortality.
  • Rural patients presented with minimal but statistically significant differences in PSA, stage, and Gleason Grade Group at diagnosis compared to urban counterparts.

Conclusions

  • Rural men experience significantly worse prostate cancer outcomes than urban men.
  • Persistent disparities in prostate cancer mortality highlight potential access-to-care issues in rural regions.
  • There is a critical need for targeted healthcare interventions to improve prostate cancer care delivery and outcomes in rural areas.

Related Concept Videos

Cancer Survival Analysis 01:21

319

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Disorders of the Male Reproductive System 01:20

289

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....

Comparing the Survival Analysis of Two or More Groups 01:20

117

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...

Actuarial Approach 01:20

53

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...